Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Masimo Corp (MASI)

Masimo Corp (MASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Masimo Announces Select Preliminary 2025 Financial Results

Complete fourth quarter and full-year 2025 financial results will be announced on Thursday, February 26, 2026

MASI : 135.04 (+0.70%)
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast...

MASI : 135.04 (+0.70%)
3 of Wall Street’s Favorite Stocks That Concern Us

3 of Wall Street’s Favorite Stocks That Concern Us

TENB : 22.55 (-1.53%)
MASI : 135.04 (+0.70%)
KTOS : 87.78 (-6.10%)
1 Healthcare Stock to Research Further and 2 That Underwhelm

1 Healthcare Stock to Research Further and 2 That Underwhelm

CVS : 77.02 (+1.74%)
MOH : 122.65 (-2.22%)
MASI : 135.04 (+0.70%)
Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)

Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)

MASI : 135.04 (+0.70%)
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

MASI : 135.04 (+0.70%)
Masimo (MASI) Stock Is Up, What You Need To Know

Masimo (MASI) Stock Is Up, What You Need To Know

MASI : 135.04 (+0.70%)
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth

Announces Long-Range Targets Including 7% - 10% Revenue CAGR Through 2028 Highlights Clear Focus on Patient Outcomes, Technology Innovation and Commercial Execution

MASI : 135.04 (+0.70%)
1 Volatile Stock to Target This Week and 2 We Ignore

1 Volatile Stock to Target This Week and 2 We Ignore

CUBI : 70.99 (-2.94%)
MASI : 135.04 (+0.70%)
ALNT : 65.63 (-1.19%)
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

UFPT : 263.44 (-1.54%)
GDRX : 2.23 (-4.29%)
MASI : 135.04 (+0.70%)
MRNA : 40.51 (-3.54%)
CLOV : 2.05 (-3.30%)

Barchart Exclusives

This Outperforming Dividend Stock Increased Its 2026 Payout by 20%: Should You Buy?
GM increased its 2026 dividend by 20%, and while its dividend yield is below Ford's, it looks like a better buy compared to the Blue Oval. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar